November 15, 2023
Susanna Stroik, PhD, and Dale Ramsden, PhD, in the Department of Biochemistry and Biophysics at the UNC School of Medicine, have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer, and prostate cancer.
November 7, 2023
UNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.
September 21, 2023
Ron Alterovitz, PhD, in the UNC Computer Science Department, and Jason Akulian, MD MPH, in the UNC School of Medicine, have shown that their steerable lung robot can autonomously maneuver the intricacies of the lung, while avoiding important lung structures.
September 11, 2023
Jane Little, MD, and Maria Boucher, MD, both in the UNC School of Medicine, detail the current struggles of patients with sickle cell disease and how we can help.
July 17, 2023
The Head and Neck Surgery team represented UNC-Chapel Hill at the 11th Annual International Conference on Head and Neck Cancer with oral and poster presentations, and a second place winning poster by Jason Tasoulas.
June 7, 2023
Adam Goldstein, MD, MPH, traveled to the White House on June 1 for the Cancer Moonshot Smoking Cessation Forum. The meeting highlighted the Biden Administration’s commitment to tackling the single biggest driver of cancer deaths in this country—smoking—and efforts underway across sectors to equitably expand access to effective smoking cessation support.
April 7, 2023
Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.
December 12, 2022
With expanded hours and telemedicine visits, the Integrative and Lifestyle Medicine Consultation Clinic serves patients affected by cancer across the UNC Health System.
December 8, 2022
UNC Health is leading the way in glioblastoma treatment with a new clinical trial. The study will evaluate the safety and tolerability of CAR-T immunotherapy in patients with recurrent or progressive glioblastoma.
November 21, 2022
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.
March 8, 2022
UNC Health will partner with Philips to implement evidence-based treatment paths using Philips Oncology Pathways software, a new clinical tool to help doctors match patients with the best possible chemotherapy regimen for their condition. The clinical content will be routinely refreshed in partnership with Harvard Medical School’s Dana-Farber Cancer Institute and other leading cancer centers across the country.
January 20, 2022
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.